My research is driven by a simple question: why do some transplanted organs thrive while others fail? I focus on the inflammatory processes that shape organ function from the moment of transplantation and long after surgery. By combining extensive clinical studies with close patient follow-up, my work seeks to generate actionable insights that improve organ utilization, reduce complications, and extend graft survival. In parallel, I lead clinical drug development within international collaborations, advancing discoveries from early biological insight to clinical testing. This translational work has now reached the clinic, including a completed first-in-human trial and the planning of larger efficacy studies, with the long-term goal of bringing new therapies into everyday transplant care.